{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:41Z","timestamp":1789913201144,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.autrev.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T12:04:32Z","timestamp":1541419472000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Arthritis in primary Sj\u00f6gren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study"],"prefix":"10.1016","volume":"18","author":[{"given":"Adrien","family":"Mirouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Fauchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Deroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeddine","family":"Dellal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Beno\u00eet","family":"Arlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Urbanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Fischer-Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdou","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"M\u00e9kinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0005","first-page":"485","article-title":"Articular manifestations of primary Sj\u00f6gren's syndrome","volume":"10","author":"Castro-Poltronieri","year":"1983","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.015_bb0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","article-title":"Articular manifestations in primary Sj\u00f6gren's syndrome: clinical significance and prognosis of 188 patients","volume":"49","author":"Fauchais","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.015_bb0015","doi-asserted-by":"crossref","first-page":"e59868","DOI":"10.1371\/journal.pone.0059868","article-title":"Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sj\u00f6gren's syndrome. Data at enrollment in the prospective ASSESS cohort","volume":"8","author":"Gottenberg","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.015_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0025","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2420","article-title":"Anti-cyclic citrullinated peptide antibodies in primary Sj\u00f6gren syndrome may be associated with non-erosive synovitis","volume":"10","author":"Atzeni","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.06.015_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren's syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.015_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000066","article-title":"ACPA-positive primary Sj\u00f6gren's syndrome: true primary or rheumatoid arthritis-associated Sj\u00f6gren's syndrome?","volume":"1","author":"Payet","year":"2015","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.015_bb0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/32.7.609","article-title":"The arthropathy of Sj\u00f6gren's syndrome","volume":"32","author":"Pease","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.015_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","article-title":"Cutaneous vasculitis in primary Sj\u00f6gren syndrome: classification and clinical significance of 52 patients","volume":"83","author":"Ramos-Casals","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0049-0172(98)80037-1","article-title":"Cryoglobulinemia in primary Sj\u00f6gren's syndrome: prevalence and clinical characteristics in a series of 115 patients","volume":"28","author":"Ramos-Casals","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.015_bb0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.52.5.360","article-title":"Hydroxychloroquine treatment for primary Sj\u00f6gren's syndrome: a two year double blind crossover trial","volume":"52","author":"Kruize","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.015_bb0060","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sj\u00f6gren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.015_bb0065","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":"Etanercept in Sj\u00f6gren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial","volume":"50","author":"Sankar","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.015_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.015_bb0075","first-page":"208","article-title":"Rituximab in central nervous system manifestations of patients with primary Sj\u00f6gren's syndrome: results from the AIR registry","volume":"30","author":"Mekinian","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.015_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2011-200086","article-title":"Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry","volume":"71","author":"Mekinian","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.015_bb0085","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3899\/jrheum.160459","article-title":"Detailed analysis of the articular domain in patients with primary Sj\u00f6gren syndrome","volume":"44","author":"Moerman","year":"2017","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.015_bb0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2018.06.015_bb0100","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10067-016-3175-3","article-title":"Polyarthritis in primary Sj\u00f6gren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up","volume":"35","author":"ter Borg","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.015_bb0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.2004.029603","article-title":"Anti-cyclic citrullinated peptide antibodies in patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Tob\u00f3n","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.autrev.2018.06.015_bb0145","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W","article-title":"Infliximab in patients with primary Sj\u00f6gren's syndrome: a pilot study","volume":"44","author":"Steinfeld","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.015_bb0150","first-page":"96","article-title":"Etanercept in the treatment of patients with primary Sj\u00f6gren's syndrome: a pilot study","volume":"31","author":"Zandbelt","year":"2004","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2018.06.015_bb0155","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study","volume":"67","author":"Dass","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150749","article-title":"Rituximab effectiveness and safety for treating primary Sj\u00f6gren's syndrome (pSS): systematic review and meta-analysis","volume":"11","author":"do Souza","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.015_bb0165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2018.06.015_bb0170","first-page":"2249","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren's syndrome: the BELISS open-label phase II study","volume":"54","author":"De Vita","year":"2015","journal-title":"Rheumatology (Oxford)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:12:53Z","timestamp":1761599573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1568997218302544"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.06.015","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arthritis in primary Sj\u00f6gren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}